Actually, breast cancer classification discriminates five different tumor subtypes and a normal breast-like group based on an immunohistochemical criteria that includes expression of estrogen (ER) and progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and neoplasm.